FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS)
Approval of AVTOZMA® (tocilizumab-anoh) intravenous infusion expands label to include treatment of adults and pediatric patients aged 2 years and older with cytokine release syndrome (CRS) AVTOMZA received FDA approval in January 2025, for multiple inflammatory indications including rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (pJIA),...
The U.S. FDA Granted Fast Track Designation to Dizal’s Birelentinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Birelentinib (DZD8586) received Fast Track Designation from the U.S. FDA for relapsed/refractory CLL/SLL Supporting data from a pooled analysis of phase I/II studies of birelentinib showed an objective response rate of 84.2% in heavily pretreated CLL/SLL patients SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed...
Ductal Carcinoma In Situ Discovery from Gynecomastia Surgery by Dr Ivan Puah
Gynecomastia can indicate underlying health concerns, including cancer, and surgery provides an opportunity to examine tissues for abnormalities. Early detection saves lives. SINGAPORE, Aug. 6, 2025 /PRNewswire/ -- Dr Ivan Puah, an MOH-accredited liposuction doctor at Amaris B. Clinic, with decades of experience in male chest contouring and gynecomastia surgery, emphasises the critical significance of adhering to rigorous...
Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinically Proven to Reduce Colic and Spit-up by 30%
New anti-colic system delivers clinically tested relief for newborn digestive discomfort BEIJING, Aug. 6, 2025 /PRNewswire/ -- Thyseed, an established name in global infant care, has announced the launch of its newborn baby bottle featuring proprietary bottom vent technology for global markets. Clinical trials confirm that this design reduces colic and spit-up by more than 30% among infants aged...
Thyseed Is Set to Support Southeast Asian Families with Safer Infant Feeding Solutions, Powered by Medical-Grade Technology
BEIJING, Aug. 6, 2025 /PRNewswire/ -- Thyseed, an established name in global infant care, recently announced plans to introduce its premium, safety-certified feeding solutions to Southeast Asian households in 2025. With an established presence in the United States, Russia, and mainland China, Thyseed is committed to extending its industry-leading safety standards to new markets. Since its inception, Thyseed has championed...
Everest Medicines Announces Full Approval of NEFECON® in Taiwan
SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON®. NEFECON® is indicated to reduce the loss of kidney function in adults with primary immunoglobulin...
From AI to Precision Medicine: Taiwan’s Smart Healthcare Innovations Shine at Taiwan Expo USA 2025
DALLAS, Aug. 6, 2025 /PRNewswire/ -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the Kay Bailey Hutchison Convention Center in Dallas, Texas, from August 14 to 16. Featuring two world-leading hospitals and eight cutting-edge companies, the pavilion highlights Taiwan's exceptional strengths in telemedicine, AI-driven solutions, and precision medicine. ...
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year
SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced its inclusion in the FTSE4Good Index Series for the third consecutive year. This recognition underscores the Company's ongoing commitment to sustainable development and its efforts to...
Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency
New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical Products Administration (NMPA) for use in hysterosalpingo...
DeerRun Debuts 2 New Life-Changing Treadmills Designed to Transform Everyday Wellness
HOUSTON, Aug. 6, 2025 /PRNewswire/ -- DeerRun has recently introduced two new treadmill models to its growing portfolio of fitness equipment: the Z20 Suitcase Treadmill, a Muse Design Gold Award winner, and the X20, a high-performance treadmill featuring a 15% auto incline and DeerRun's first full-length running deck. DeerRun Debuts 2 New Life-Changing Treadmills Designed to Transform Everyday...
